axl010

Adam J. Luginbuhl, MD

Contact Dr. Luginbuhl

925 Chestnut Street
6th Floor
Philadelphia, PA 19107

(215) 955-5208

Most Recent Peer-reviewed Publications

  1. Tumor Metabolism in the Microenvironment of Nodal Metastasis in Oral Squamous Cell Carcinoma
  2. Positron emission tomography/computed tomography after primary transoral robotic surgery for oropharyngeal squamous cell carcinoma
  3. Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes
  4. Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial
  5. Macrophage type 2 differentiation in a patient with laryngeal squamous cell carcinoma and metastatic prostate adenocarcinoma to the cervical lymph nodes
  6. Morbidity and Survival in Elderly Patients Undergoing Free Flap Reconstruction: A Retrospective Cohort Study
  7. Pathologic Markers in Surgically Treated HPV-Associated Oropharyngeal Cancer: Retrospective Study, Systematic Review, and Meta-analysis
  8. Sialendoscopy for Sublingual Gland Sialolithiasis: A Novel Technique
  9. Prospective, randomized, controlled trial using best-selling smoking-cessation book
  10. Safety and efficacy of functional laryngectomy for end-stage dysphagia
  11. Multicompartment metabolism in papillary thyroid cancer
  12. Transoral robotic approach to parapharyngeal space tumors: Case series and technical limitations
  13. Effects of a Fibrin Sealant on Skin Graft Tissue Adhesion in a Rodent Model
  14. Nonvisualization of sialoliths during sialendoscopy
  15. Cervical spine spondylodiscitis after esophageal dilation in patients with a history of laryngectomy or pharyngectomy and pharyngeal irradiation
  16. Exosome-mediated transfer from the tumor microenvironment increases TGFβ signaling in squamous cell carcinoma
  17. Styloid/C1 transverse process juxtaposition as a cause of Eagle's syndrome
  18. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
  19. Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer
  20. Subcutaneous vs Intramuscular Botulinum Toxin split-face randomized study